Literature DB >> 24750325

Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: a case-control study.

Perla Sravan Kumar1, Palghat Hariharan Ananthanarayanan, Soundravally Rajendiran.   

Abstract

AIM: To study thyroid function profile, atherogenic markers and their association in young women with PCOS.
METHODS: Thirty women aged 15-30 years with PCOS (married and unmarried) and an equal number of age-matched controls were included in this study. The following parameters were assessed: thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), tetraiodothyronine (FT4), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C) homocysteine (HCY), lipoprotein(a) (Lp[a]) levels.
RESULTS: Thyroid function tests were within normal ranges in all the cases and controls. The following parameters were significantly elevated in women with PCOS compared to controls: serum TC, TG, LDL,VLDL, HCY and Lp(a). Married women with PCOS had significantly higher levels of TC, TG, VLDL-C, LDL-C, HCY and Lp(a). Among unmarried PCOS cases, HCY levels were found to be significantly higher compared to unmarried controls. In group 1, Lp(a) levels were found to be high. In group 2, TC, TG, LDL-C, VLDL-C, Lp(a) and HCY levels were found to be high. In group 3, TC, VLDL-C and Lp(a) were found to be high.
CONCLUSION: Alteration in lipid metabolism and elevated HCY and Lp(a) levels were present in women with PCOS, which were independent of their thyroid status. Unmarried PCOS women are predisposed to develop cardiovascular diseases rather than married PCOS women. Group 2 PCOS women are predisposed to get cardiovascular diseases rather than group 1 and group 3. PCOS women need not have hypothyroidism.
© 2014 The Authors. Journal of Obstetrics and Gynaecology Research © 2014 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  atherogenic markers; homocysteine; lipid profile; polycystic ovarian syndrome; thyroid profile

Mesh:

Substances:

Year:  2014        PMID: 24750325     DOI: 10.1111/jog.12346

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

1.  Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.

Authors:  Lan Li; Ji Eun Ryoo; Kyung-Ju Lee; Bum-Chae Choi; Kwang-Hyun Baek
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

2.  Association between blood lipid level and embryo quality during in vitro fertilization.

Authors:  Shanshan Wang; Jun Wang; Yiqun Jiang; Weihua Jiang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.